VAERS reports by lot

Pfizer COVID-19 lot 59267-1000-02: VAERS reports

24 VAERS reports list lot 59267-1000-02 as a Pfizer COVID-19 vaccine, received between 2021-03-14 and 2022-02-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
8%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3233%
Neurological1717%
Musculoskeletal1515%
Cardiac / Cardiovascular1212%
Gastrointestinal1010%
Injection-site / Local reaction44%
Allergic / Anaphylactic22%
Respiratory22%
Dermatological (non-injection-site)22%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Tennessee4
California4
Missouri2
Texas2
Wisconsin2
Iowa2
Ohio1
Nebraska1
Washington1
Michigan1
Utah1
Florida1

Reports by month received

2021-032
2021-045
2021-054
2021-061
2021-082
2021-094
2021-102
2021-122
2022-011
2022-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.